Table 1 Baseline characteristics of participants included in the primary outcome analysis.
Placebo | SH60 | SH120 | |
|---|---|---|---|
Number | 50 | 47 | 50 |
Female/male | 32/18 | 31/16 | 32/18 |
Age, mean ± SD | 43.4 ± 10.8 | 44.3 ± 8.8 | 43.8 ± 9.2 |
Age, range | 18–60 | 22–59 | 24–60 |
Fitzpatrick phototype I/II/III | 3/45/2 | 2/43/2 | 3/44/3 |